PolyNovo (ASX:PNV) said its monthly sales reached a record AU$10.1 million in November, up from AU$8.8 million a year earlier, according to a Monday filing with the Australian bourse.
US sales came in at AU$7 million, while sales from the rest of the world stood at AU$3.1 million.
Total group revenue for the month, including income from the US Biomedical Advanced Research Development Authority, was AU$11 million, the filing said. Year to date, group revenue climbed over 25% year on year to AU$49.6 million in November.
The medical device maker's shares were up nearly 6% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.